FDCs inhibit spontaneous apoptosis in vitro through direct cell–cell interactions that are mediated by the ligation of CD44 on CLL cells [66] and the engagement of semaphoring CD100 expressed on CLL cells and its counter receptor plexin B1 [67]. The gene discussed is CD44; the disease is B-cell chronic lymphocytic leukemia.